Networks
Networks
Examining the past and looking toward the future: The need for quality data in interventional pulmonology
During the last decade, the explosion of technological advancements in the field of interventional pulmonary (IP) has afforded patients the...
Networks
Updates in evidence for rituximab in interstitial lung disease
Interstitial lung diseases (ILD) are a heterogeneous group of fibro-inflammatory disorders that can be progressive despite available therapies.
Networks
Networks at CHEST 2023
CHEST Networks mark a successful year at 2023 annual meeting.
Networks
Thoracic ultrasound advancements for the assessment and management of pleural disorders
Thoracic ultrasound (TUS) is standard of care for the detection of pleural effusion and guidance of pleural procedures.
Networks
Seasonal variations in sleep architecture
Do you feel like you sleep worse in the spring and have more difficulty keeping your schedule on track?
Networks
The crucial roles of inpatient vaccinations in preventing respiratory viral illnesses
The crucial roles of inpatient vaccinations in preventing respiratory viral illnesses
In recent years, the importance of inpatient...
Networks
Update on seasonal flu, RSV infections, and vaccines
November 12 marks World Pneumonia Day, and while it has long been recognized that viruses play a significant role in causing pneumonia, awareness...
Networks
Updated pleural disease guidelines from the British Thoracic Society
After more than a decade, the British Thoracic Society released updated guidelines for pleural disease.
Networks
CPAP in overlap syndrome: Unveiling the evidence
The overlap syndrome (OS), which refers to the co-occurrence of OSA and COPD, was first described by Flenley in 1985.
Networks
Use of 6-minute walk distance as a clinical trial outcome in interstitial lung disease
Pulmonary arterial hypertension (PH) and more recently interstitial lung disease (ILD) trials use the 6-minute walk test (6MWT) as a primary...